Loading insider details...
Latest Form 4 (Sep 17, 2026): Exercise/Conversion of 18,421 TRVI shares, $56.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Trevi Therapeutics, Inc. (TRVI) | Exercise/Conversion | 18,421 | $56.0K |
| Jun 17, 2026 | enGene Therapeutics Inc. (ENGN) | Grant/Award | 31,000 | n/a |
| Jun 4, 2026 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 29,500 | n/a |
| Jun 4, 2026 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 35,000 | n/a |
| May 1, 2026 | Biohaven Ltd. (BHVN) | Grant/Award | 68,693 | n/a |
| Jul 10, 2025 | enGene Holdings Inc. (ENGN) | Grant/Award | 45,000 | n/a |
| Jun 18, 2025 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 29,500 | n/a |
| Jun 13, 2025 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 45,000 | n/a |
| May 7, 2025 | Biohaven Ltd. (BHVN) | Grant/Award | 31,716 | n/a |
| Mar 26, 2025 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 50,000 | n/a |